v3.26.1
BACKGROUND AND ORGANIZATION (Details Narrative)
Aug. 30, 2022
₨ / shares
shares
Jun. 30, 2026
$ / shares
shares
May 08, 2026
$ / shares
shares
Jan. 23, 2026
$ / shares
shares
Dec. 31, 2025
$ / shares
shares
Oct. 25, 2024
Mar. 17, 2022
$ / shares
shares
Sep. 21, 2018
$ / shares
shares
Oct. 05, 2017
$ / shares
shares
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                  
Common stock, shares authorized   400,000,000     400,000,000        
Common stock par value | $ / shares   $ 0.001 $ 0.06 $ 0.06 $ 0.001        
Preferred stock, shares authorized   50,000,000     50,000,000        
Preferred stock, par value | $ / shares   $ 0.001     $ 0.001        
Common stock, shares issued   114,695,220 1,440,001 4,716,000 108,147,731        
Common stock, shares outstanding   114,695,220     108,147,731        
Pharmalectin India Pvt Ltd [Member]                  
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                  
Common stock, shares authorized 50,000                
Common stock par value | ₨ / shares ₨ 10                
Common stock, shares outstanding 41,020                
Outstanding shares held 41,000                
Outstanding shares percentage 99.95%                
Pharmalectin (BVI), Inc. [Member]                  
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                  
Common stock, shares authorized             50,000    
Common stock par value | $ / shares             $ 1.00    
Outstanding shares held             50,000    
NDPD Pharma Inc [Member]                  
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                  
Common stock, shares authorized                 95,000,000
Preferred stock, par value | $ / shares                 $ 0.0001
Common stock, shares issued   15,000,000              
Common stock, shares outstanding   15,000,000              
Common stock acquired percentage           100.00%      
Parent Company [Member]                  
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                  
Common stock, shares authorized               400,000,000 95,000,000
Common stock par value | $ / shares               $ 0.001 $ 0.0001
Preferred stock, shares authorized               50,000,000 5,000,000
Preferred stock, par value | $ / shares               $ 0.001 $ 0.0001
Pharmalectin, Inc. [Member]                  
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                  
Common stock, shares authorized                 95,000,000
Common stock par value | $ / shares                 $ 0.0001
Preferred stock, shares authorized                 5,000,000
Preferred stock, par value | $ / shares                 $ 0.0001
Common stock, shares issued   15,000,000              
Common stock, shares outstanding   15,000,000              
NDPD Pharma Inc [Member]                  
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                  
Common stock par value | $ / shares                 $ 0.0001
Preferred stock, shares authorized                 5,000,000